BioStock: 10 advantages of Stayble’s treatment
Stayble Therapeutics’ injectable and lactic acid-based drug candidate STA363 triggers a connective tissue transformation in the spinal disc, which is expected to provide long-term pain relief for patients with discogenic chronic low back pain. BioStock deep dive into the benefits of STA363.Read the full article at biostock.se: https://www.biostock.se/en/2022/06/10-advantages-of-staybles-treatment/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se